Arkadios Wealth Advisors’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $361K | Sell |
13,099
-1,045
| -7% | -$28.8K | 0.01% | 959 |
|
|
2025
Q1 | $401K | Buy |
14,144
+1,879
| +15% | +$53.3K | 0.02% | 790 |
|
|
2024
Q4 | $510K | Buy |
12,265
+836
| +7% | +$34.8K | 0.03% | 537 |
|
|
2024
Q3 | $764K | Buy |
11,429
+243
| +2% | +$16.2K | 0.04% | 397 |
|
|
2024
Q2 | $1.33M | Buy |
11,186
+282
| +3% | +$33.5K | 0.09% | 225 |
|
|
2024
Q1 | $1.16M | Sell |
10,904
-834
| -7% | -$88.9K | 0.09% | 213 |
|
|
2023
Q4 | $1.17M | Sell |
11,738
-751
| -6% | -$74.7K | 0.1% | 194 |
|
|
2023
Q3 | $1.29M | Buy |
12,489
+86
| +0.7% | +$8.88K | 0.12% | 174 |
|
|
2023
Q2 | $1.51M | Sell |
12,403
-822
| -6% | -$99.9K | 0.18% | 139 |
|
|
2023
Q1 | $2.03M | Sell |
13,225
-102
| -0.8% | -$15.7K | 0.24% | 113 |
|
|
2022
Q4 | $2.39M | Sell |
13,327
-50
| -0.4% | -$8.98K | 0.32% | 87 |
|
|
2022
Q3 | $1.58M | Buy |
13,377
+350
| +3% | +$41.4K | 0.24% | 114 |
|
|
2022
Q2 | $1.86M | Buy |
13,027
+10
| +0.1% | +$1.43K | 0.28% | 97 |
|
|
2022
Q1 | $2.24M | Buy |
13,017
+911
| +8% | +$157K | 0.29% | 87 |
|
|
2021
Q4 | $3.08M | Buy |
12,106
+309
| +3% | +$78.5K | 0.41% | 58 |
|
|
2021
Q3 | $4.54M | Buy |
11,797
+270
| +2% | +$104K | 0.65% | 23 |
|
|
2021
Q2 | $2.71M | Buy |
11,527
+260
| +2% | +$61.1K | 0.33% | 77 |
|
|
2021
Q1 | $1.48M | Buy |
11,267
+3,735
| +50% | +$489K | 0.24% | 107 |
|
|
2020
Q4 | $786K | Buy |
7,532
+996
| +15% | +$104K | 0.16% | 138 |
|
|
2020
Q3 | $483K | Buy |
6,536
+2,686
| +70% | +$199K | 0.24% | 94 |
|
|
2020
Q2 | $289K | Buy |
3,850
+850
| +28% | +$63.8K | 0.16% | 131 |
|
|
2020
Q1 | $89.9K | Buy |
+3,000
| New | +$89.9K | 0.06% | 243 |
|